Oncotarget #published this #editorial on November 27, 2023, entitled, “The double-edge sword of CRISPR application for in vivo studies” by Martin K. Thomsen @AarhusUni. https://t.co/ykdeKHy7Tg #cancer #invivo #cells #openaccess #peerreview #research #on
Oncotarget #published this #editorial on November 27, 2023, entitled, “The double-edge sword of CRISPR application for in vivo studies” by Martin K. Thomsen @AarhusUni. https://t.co/ykdeKHy7Tg #cancer #invivo #cells #openaccess #peerreview #research #on
RT @Oncotarget: #PaperoftheDay: "The double-edge sword of CRISPR application for in vivo studies" DOI: https://t.co/dJPtFYGP6y #cancerres…
#PaperoftheDay: "The double-edge sword of CRISPR application for in vivo studies" DOI: https://t.co/dJPtFYGP6y #cancerresearch #oncology #MedEd
The double-edge sword of CRISPR application for in vivo studies https://t.co/eqvd6iBmzV
The double-edge sword of CRISPR application for in vivo studies https://t.co/4WWk9vrF6I https://t.co/yQ5DbQmuAS
#PaperSpotlight: On November 27, 2023, researcher Martin K. Thomsen from @AarhusUni published a new editorial paper in #Oncotarget, entitled, “The double-edge sword of CRISPR application for in vivo studies” DOI: https://t.co/ykdeKHy7Tg #CRISPR #mousemod
Oncotarget #published this #editorial on November 27, 2023, entitled, “The double-edge sword of CRISPR application for in vivo studies” by Martin K. Thomsen @AarhusUni. https://t.co/ykdeKHy7Tg #cancer #invivo #cells #openaccess #peerreview #research #on